...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Trial

Bear did you see they have extended the Prostate trial for those that benefited from the drug as of Nov 11th till 2022

4
Nov 21, 2019 01:09PM
6
Nov 21, 2019 01:21PM
5
Nov 21, 2019 01:48PM
6
Nov 21, 2019 01:49PM
7
Nov 21, 2019 02:15PM
6
Nov 21, 2019 02:30PM
7
Nov 21, 2019 02:47PM
Share
New Message
Please login to post a reply